<unk>  is a gastrointestinal agent that is FDA approved for the treatment of of oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID)..   Common adverse reactions include abdominal pain, constipation, diarrhea, nausea, vomiting, headache, insomnia, dehydration.
Sacrosidase
Clostridiopeptidase
Saruplase
Agalsidase beta
Glucuronosyltransferase
Pegaspargase
Isozyme
Alglucerase